Tilray Brands Subsidiary is First Company in Italy Approved to Distribute Medical Cannabis Flower

FL Group, a wholly owned subsidiary of Tilray Brands Inc., has become the
first company in Italy to receive government approval to distribute medical
cannabis flower. The products are set to be available this month in
pharmacies throughout the country.

In a statement, Denise Faltischek, chief strategy officer and head of
International at Tilray Brands, said the “milestone underscores the vital
role of medical cannabis as a therapeutic medicine for patients in need,
supporting their health and well-being.”

“We are proud to expand our medical cannabis portfolio in Italy with the
introduction of our Tilray Medical high-quality, EU-GMP certified medical
cannabis products that uphold the highest standards in patient care,”
Faltischek said. “We extend our gratitude to the Ministero della Salute
(Italian Ministry of Health) for their trust in Tilray Medical and for
providing the necessary regulatory framework to ensure access to safe,
consistent and reliable cannabinoid-based therapies. Together, we are
advancing health care and patient wellness through innovation and
collaboration.” — Faltischek in a press release

The three approved products include Tilray Medical’s Tilray THC 25%, Tilray
THC 18%, and Tilray THC 9%/CBD 9%.

Italy legalized medical cannabis in 2013 and initially relied on imported
medical cannabis products; however, the Italian Army was later tasked with
local cultivation at the Military Pharmaceutical Plant in Florence, which
was criticized for producing low quality flower.